Crinetics Pharmaceuticals, Inc. Deferred Compensation Arrangement with Individual, Compensation Expense
Crinetics Pharmaceuticals, Inc. (CRNX) reported Deferred Compensation Arrangement with Individual, Compensation Expense of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense · last filed 2026-08-03
- Crinetics Pharmaceuticals, Inc. deferred compensation arrangement with individual, compensation expense for the quarter ending 2026-06-30 was $0.00.
- Crinetics Pharmaceuticals, Inc. deferred compensation arrangement with individual, compensation expense for the quarter ending 2026-03-31 was $0.00.
- Crinetics Pharmaceuticals, Inc. deferred compensation arrangement with individual, compensation expense for the quarter ending 2025-06-30 was $0.00.
- Crinetics Pharmaceuticals, Inc. deferred compensation arrangement with individual, compensation expense for fiscal 2025 was $0.00.
| Period end | Deferred Compensation Arrangement with Individual, Compensation Expense 3 month | Deferred Compensation Arrangement with Individual, Compensation Expense 6 month | Deferred Compensation Arrangement with Individual, Compensation Expense 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-03 | $0.00 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | ||
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-03 | $0.00 10-Q · filed 2026-08-03 |